THE GREAT BRITAIN: MED TECH/HEALTHCARE SECTOR

Oxford Cardiomox Ltd.

Contact Person, Position

  • Project Name

 

Oxford Cardiomox Ltd was formed in 2014 by Oxford University Innovation Ltd. The technology was identified during a consulting project to support a leading Ukrainian medical research institute. A Chinese sister company was created in 2016 to access government support and ease entry to the Chinese market. The company raised £2m in 2014. These funds are being used to complete the regulatory approval process for the current Cardiomox MCG scanner in China and Europe. We are now seeking £3m to accelerate sales in China and support entry to the US market.

 

Innovations offered:

  1. Extremely sensitive magnetic sensors (SQUIDs) combined with unique software are used to create current density vectors map and can automatically analyze the result, which reflect the electrophysiological condition of the heart. The system assists cardiologists to identify the early signs of Coronary Artery Disease (often before symptoms occur).
  2. It supports rapid identification of arrhythmias and other heart conditions. The technology can be used in large scale of health checking or screening.

 

Currently:

□ Under development, Lab tested

□ Available for demonstration

□ Field tested, ready for commercialization and scale up

□ Already on market

 

Preferred Cooperation:

□ Commercial Agreement with technical assistance

□ Technical Cooperation Agreement

□ Financial Investment Agreement

□ Joint Venture

□ Licensing Agreement

□ Manufacturing Agreement

□ Research Collaboration Agreement

□ Services Agreement

 

Type of Partner sought:

Copyright © 2018 CHINA INTERNATIONAL TECHNOLOGY TRANSFER CENTER